Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Updated:
May 14, 2024
Fusion Antibodies PLC
Total Receivables
|
Fusion Antibodies PLC
Total Receivables Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Total Receivables
£797k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Receivables
£75.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Receivables
£10.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Total Receivables
£10.4m
|
CAGR 3-Years
18%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Total Receivables
£38.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Total Receivables
£14.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
38%
|
See Also
What is Fusion Antibodies PLC's Total Receivables?
Total Receivables
797k
GBP
797k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Receivables amounts to 797k GBP.
What is Fusion Antibodies PLC's Total Receivables growth rate?
Total Receivables CAGR 5Y
4%
4%
Over the last year, the Total Receivables growth was -46%. The average annual Total Receivables growth rates for Fusion Antibodies PLC have been -14% over the past three years , 4% over the past five years .
You don't have any saved screeners yet
